Close
4

Seqens Seqens

X

Company profile for Novimmune SA

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Novimmune SA is a privately held, Swiss biopharmaceutical company. Novimmune has been granted Breakthrough therapy designation for emapalumab by the US Food and Drug Administration (FDA) and was also selected for PRIME (PRIority MEdicine) by the European Medicines Agency (EMA). Novimmune has signed two exclusive partnering agreements with Genentech, a member of the Roche Group: in 2010 on an anti-IL17 and in 2016 on an anti-TL...
Novimmune SA is a privately held, Swiss biopharmaceutical company. Novimmune has been granted Breakthrough therapy designation for emapalumab by the US Food and Drug Administration (FDA) and was also selected for PRIME (PRIority MEdicine) by the European Medicines Agency (EMA). Novimmune has signed two exclusive partnering agreements with Genentech, a member of the Roche Group: in 2010 on an anti-IL17 and in 2016 on an anti-TLR4 monoclonal antibody. Novimmune is currently performing a phase 2 study in Rheumatoid Arthritis, with this latter molecule, with results expected in the third quarter 2018.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Novimmune SA
Switzerland Flag
Country
Country
Switzerland
Address
Address
14 Chemin des Aulx 1228 Plan-Les-Ouates Geneva – Switzerland
Telephone
Telephone
+41 22 839 71 41
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY